Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
Titel:
Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): a randomised, double-blind, phase 3 trial
Auteur:
Ramalingam, Suresh S Jänne, Pasi A Mok, Tony O'Byrne, Kenneth Boyer, Michael J Von Pawel, Joachim Pluzanski, Adam Shtivelband, Mikhail Docampo, Lara Iglesias Bennouna, Jaafar Zhang, Hui Liang, Jane Q Doherty, Jim P Taylor, Ian Mather, Cecile B Goldberg, Zelanna O'Connell, Joseph Paz-Ares, Luis